Literature DB >> 21905009

Structural changes of the brain in rheumatoid arthritis.

Karolina Wartolowska1, Morgan G Hough, Mark Jenkinson, Jesper Andersson, B Paul Wordsworth, Irene Tracey.   

Abstract

OBJECTIVE: To investigate whether structural changes are present in the cortical and subcortical gray matter of the brains of patients with rheumatoid arthritis (RA).
METHODS: We used two surface-based style morphometry analysis programs and a voxel-based style analysis program to compare high-resolution structural magnetic resonance imaging data obtained for 31 RA patients and 25 age- and sex-matched healthy control subjects.
RESULTS: We observed an increase in gray matter content in the basal ganglia of RA patients, mainly in the nucleus accumbens and caudate nucleus. There were no differences in the cortical gray matter. Moreover, patients had a smaller intracranial volume.
CONCLUSION: Our results suggest that RA is associated with changes in the subcortical gray matter rather than with cortical gray matter atrophy. Since the basal ganglia play an important role in motor control as well as in pain processing and in modulating behavior in response to aversive stimuli, we suggest that these changes may result from altered motor control or prolonged pain processing. The differences in brain volume may reflect either generalized atrophy or differences in brain development.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 21905009     DOI: 10.1002/art.33326

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  41 in total

1.  A Verbal Fluency Task-Based Brain Activation fMRI Study in Patients with Crohn's Disease in Remission.

Authors:  Veena A Nair; Keith Dodd; Shruti Rajan; Anu Santhanubosu; Poonam Beniwal-Patel; Sumona Saha; Vivek Prabhakaran
Journal:  J Neuroimaging       Date:  2019-05-27       Impact factor: 2.486

Review 2.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

Review 3.  A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process.

Authors:  Jaymin Upadhyay; Christian Geber; Richard Hargreaves; Frank Birklein; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2017-08-12       Impact factor: 8.989

4.  Different coexpressions of arthritis-relevant genes between different body organs and different brain regions in the normal mouse population.

Authors:  Yanhong Cao; Yue Huang; Lishi Wang; Jiaqian Zhu; Weikuan Gu
Journal:  Gene       Date:  2012-12-21       Impact factor: 3.688

5.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 6.  Structural plasticity and reorganisation in chronic pain.

Authors:  Rohini Kuner; Herta Flor
Journal:  Nat Rev Neurosci       Date:  2016-12-15       Impact factor: 34.870

Review 7.  Mechanisms, impact and management of pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Nat Rev Rheumatol       Date:  2014-05-27       Impact factor: 20.543

Review 8.  Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment.

Authors:  Irene Tracey; Clifford J Woolf; Nick A Andrews
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

9.  Reply to commentary.

Authors:  Michael E Robinson; Roland Staud; Donald D Price
Journal:  J Pain       Date:  2013-04       Impact factor: 5.820

Review 10.  Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume.

Authors:  Rachel F Smallwood; Angela R Laird; Amy E Ramage; Amy L Parkinson; Jeffrey Lewis; Daniel J Clauw; David A Williams; Tobias Schmidt-Wilcke; Michael J Farrell; Simon B Eickhoff; Donald A Robin
Journal:  J Pain       Date:  2013-05-17       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.